Translating New Noninvasive Screening Methodologies to Clinical Practice
Honey Reddi, PhD, FACMG
With biomarker research rapidly evolving, liquid biopsies are set to become the cornerstone of clinical cancer screening
Honey Reddi, PhD, FACMG
Honey Reddi, PhD, FACMG, served as a professor and chief of the Division of Clinical Genomics at the Medical College of Wisconsin before joining Belay Diagnostics LLC, IL, as senior vice president and medical director. Reddi has a background in biotechnology and specialized training in clinical molecular genetics from the Mayo Clinic, where she led a translational research program on thyroid cancer. Reddi received the 2023 Outstanding Graduate Educator award and the 2018 Women of Innovation Award for her leadership in bioscience and technology. Her research interests include cancer biology, viro-therapeutics, and genetics of somatic and inherited disorders. Reddi is passionate about impacting patient care through innovation and translation and mentoring the next generation of laboratory geneticists.